Litigation Details for Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd. (D. Del. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-07-30 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | DANA-FARBER CANCER INSTITUTE, INC. | ||
| Patents | 7,973,031; 8,222,244; 8,575,146 | ||
| Attorneys | Steven H. Sklar | ||
| Firms | Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-07-30 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,973,031 ;8,222,244 ;8,575,146… 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-04-06 | 45 | Stipulation of Dismissal | Claims Against Defendant Lotus Regarding U.S. Patent No. 8,222,244 Pursuant to Rule 41(a)(1)(A)(iii) Without… 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-07-15 | 59 | Notice of Service | Defendants Invalidity Contentions Regarding U.S. Patent Nos. 7,973,031 and 8,575,146 filed by Dana-Farber Cancer… 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-12-19 | 70 | Notice of Service | Final Non-Infringement Claim Chart for U.S. Patent No. 7,973,031 [HIGHLY CONFIDENTIAL] filed by Lotus Pharmaceutical….'s Final Non-Infringement Claim Chart for U.S. Patent No. 8,575,146 [HIGHY CONFIDENTIAL]; and, (iii) … 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-12-19 | 71 | Notice of Service | Final Invalidity Contentions Regarding U.S. Patent Nos. 7,973,031 and 8,575,146 filed by Dana-Farber Cancer… 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-06-05 | 86 | Notice of Service | Rotella, Ph.D., on the Invalidity of U.S. Patent Nos. 7,973,031 and 8,575,146 2. Opening Expert Report of… M.D., regarding the Invalidity of U.S. Patent Nos. 7, 973,031 and 8,575,146 3. Opening Expert Report … 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
